RLYB (Rallybio Corporation Common Stock) Stock Analysis - SEC Filings

Rallybio Corporation Common Stock (RLYB) is a publicly traded Healthcare sector company. As of May 21, 2026, RLYB trades at $14.43 with a market cap of $74.70M and a P/E ratio of -5.06. RLYB moved +2.18% today. Year to date, RLYB is +168.41%; over the trailing twelve months it is +427.04%. Its 52-week range spans $1.76 to $15.31. Rallies surfaces RLYB's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.

Where can I find RLYB SEC filings?

Rallies organizes RLYB SEC filing research, company disclosures, 10-K reports, 10-Q reports, and filing-driven context alongside market data, news, fundamentals, and AI research.

RLYB Key Metrics

Key financial metrics for RLYB
MetricValue
Price$14.43
Market Cap$74.70M
P/E Ratio-5.06
EPS$-2.84
Dividend Yield0.00%
52-Week High$15.31
52-Week Low$1.76
Volume86
Avg Volume0
Revenue (TTM)$858.00K
Net Income$-7.82M
Gross Margin0.00%

Latest RLYB News

Recent RLYB Insider Trades

  • ADAR1 Capital Management, LLC bought 10.00K (~$139.82K) on May 19, 2026.
  • ADAR1 Capital Management, LLC bought 200 (~$2.76K) on May 19, 2026.
  • ADAR1 Capital Management, LLC bought 6.01K (~$83.98K) on May 18, 2026.

RLYB Analyst Consensus

RLYB analyst coverage data. Average price target: $0.00.

Common questions about RLYB

Where can I find RLYB SEC filings?
Rallies organizes RLYB SEC filing research, company disclosures, 10-K reports, 10-Q reports, and filing-driven context alongside market data, news, fundamentals, and AI research.
Does Rallies show RLYB 10-K and 10-Q filings?
Rallies organizes RLYB SEC filing research, including 10-K reports, 10-Q reports, company disclosures, and filing-driven context when available.
Is RLYB research on Rallies investment advice?
No. Rallies provides research, data, and educational context for RLYB. It does not provide personalized investment advice.
RLYB

RLYB